Retrophin

1 stories about Retrophin
default image

Censa Pharmaceuticals Signs Joint Development Agreement with Biotech Company Retrophin

07.01.18|Lilach Baumer
Censa, a company developing treatments for orphan metabolic diseases, is a portfolio company of Israel-based Arkin Bio Ventures